Treatment Issues Section Bibliography

• Azathioprine Package Insert. Salix Pharmaceuticals. Accessed at http://salix.com . Accessed August 8, 2006.
• Constantinescu CS, Chang AP, McClusky LF. Recurrent migraine and intravenous immune globulin therapy. N Engl J Med. 1993;329:583-584.
• Cyclophoshamide product information. Accessed at http://en.wikipedia.org/wiki/Cyclophoshamide. Accessed August 8, 2006.
• Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004;291:2367-2375.
• Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve 1999;22:1479-1497.
• Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Therapeut. 2004;102:177-193.
• Drug Information: Etanercept Injection. Accessed at http://www.nlm.nih.gov/medlineplus/print/druginfo/. Accessed August 8, 2006.
• Hahn AF, Bolton CF, Xochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996;119:1067-1077.
• Interferon A product information. Accessed at http://www.cancerhelp.org.uk. Accessed August 8, 2006.
• Joint Task Force, 2005 European Federation of Neurological Societies; Peripheral Nerve Society, Hadden RD, Nobile-Orazio E, Sommer C, Hahn A, Illa I, Morra E, Pollard J, Hughes RA, Bouche P, Cornblath D, Evers E, Koski CL, Leger JM, Van den Bergh P, van Doorn P, van Schaik IN; European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006 Aug;13(8):809-18.
• Kornberg AJ. Clinical experience with intravenous immunoglobulin for treatment of pediatric Guillain Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. In MC Dalakas & PJ Spath, Eds, Intravenous Immunoglobulin in the Third Millennium. Lancaster, UK: Parthenon: 181-185.
• Koski, Carol Lee, Initial and Long Term Management of Autoimmune Neuropathies, CNS Drugs, Volume 19, Number 12, 2005 , pp. 1033-1048(16).
• McCrone P, Chisholm D, Knapp M, et al. and the INCAT Gropu. Cost-utility analysis of intravenous immunoglobulin and polyradiculoneuropathies (CIDP). Eur J Neurol. 2002;10:687-694.
• McCrone P, Chisholm D, Knapp M, Hughes R, Comi G, Dalakas MC, Illa I, Kilindireas C, Nobile-Orazio E, Swan A, Van den Bergh P, Willison HJ; The INCAT Study Group., Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2003 Nov;10(6):687-94.
• Mycophenolate mofetil Package Insert. Roche.
• Nevo V, Pestronk A, Kornberg AJ, et al. Childhood chronic inflammatory demyelinating neuopathies: clinical course and long-term follow-up. Neurology 1996;47:98-102.
• Rituxan Full Prescribing Information accessed at http://www.gene.com/gene/products/information/oncology/rituxan. Accessed August 8, 2006.
• Ropper AH, Current treatments for CID, Neurology. 2003 Apr 1;60(8 Suppl 3):S16-22. Review.
• Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol. 2002;59:758-765.
• Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994;121:259-262.
• Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up with comparison to adults. Muscle Nerve 1997;20:1569-1575.
• Steg RE, Lefkowitz DM. Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis. Neurology 1994;44:1180-1181.
• Vermeulen M, van Doorn PA Brand A, et al. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo controlled study. J Neurol Neurosurg Psychiat. 1993;56:36-39.